At a satellite conference held in Paris, France during the International Medication Safety Network meeting on Thursday October 10, 2013 Continue reading →

The 8th annual meeting of the International Medication Safety Network will be held on October 11 & 12, 2013 in Paris, France. An International Conference on safer naming, labelling and packaging of medications will be held on October 10.

IMSN_2013_Paris_Conference_Programme (PDF)

On February 22, 2013, the US Food and Drug Administration (FDA)approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists. For more information.